Literature DB >> 18593910

Gamma-irradiation-induced DNA damage checkpoint activation involves feedback regulation between extracellular signal-regulated kinase 1/2 and BRCA1.

Ying Yan1, Claudine P Black, Phu T Cao, Jamie L Haferbier, Ryan H Kolb, Rebecca S Spieker, Alexandra M Ristow, Kenneth H Cowan.   

Abstract

Previous studies from our laboratory have shown that the activation of G(2)-M checkpoint after exposure of MCF-7 breast cancer cells to gamma-irradiation (IR) is dependent on the activation of extracellular signal-regulated kinase 1/2 (ERK1/2) signaling. Studies presented in this report indicate that IR exposure of MCF-7 cells is associated with a marked increase in expression of breast cancer 1 (BRCA1) tumor suppressor, an effect that requires ERK1/2 activation and involves posttranscriptional control mechanisms. Furthermore, reciprocal coimmunoprecipitation, as well as colocalization studies, indicate an interaction between BRCA1 and ERK1/2 in both nonirradiated and irradiated cells. Studies using short hairpin RNA targeting BRCA1 show that BRCA1 expression is necessary for IR-induced G(2)-M cell cycle arrest, as well as ERK1/2 activation in MCF-7 cells. Although BRCA1 expression is not required for IR-induced phosphorylation of ataxia telangiectasia mutated (ATM)-Ser1981, it is required for ATM-mediated downstream signaling events, including IR-induced phosphorylation of Chk2-Thr68 and p53-Ser20. Moreover, BRCA1 expression is also required for IR-induced ATM and rad3 related activation and Chk1 phosphorylation in MCF-7 cells. These results implicate an important interaction between BRCA1 and ERK1/2 in the regulation of cellular response after IR-induced DNA damage in MCF-7 cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18593910      PMCID: PMC3674789          DOI: 10.1158/0008-5472.CAN-07-5818

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  44 in total

1.  Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation.

Authors:  B Xu; M B Kastan
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

2.  Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies.

Authors:  M Gatei; B B Zhou; K Hobson; S Scott; D Young; K K Khanna
Journal:  J Biol Chem       Date:  2001-02-13       Impact factor: 5.157

3.  BRCA1 facilitates stress-induced apoptosis in breast and ovarian cancer cell lines.

Authors:  M Thangaraju; S H Kaufmann; F J Couch
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

4.  Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.

Authors:  I Garcia-Higuera; T Taniguchi; S Ganesan; M S Meyn; C Timmers; J Hejna; M Grompe; A D D'Andrea
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

5.  ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1.

Authors:  H Zhao; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

6.  Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.

Authors:  Q Liu; S Guntuku; X S Cui; S Matsuoka; D Cortez; K Tamai; G Luo; S Carattini-Rivera; F DeMayo; A Bradley; L A Donehower; S J Elledge
Journal:  Genes Dev       Date:  2000-06-15       Impact factor: 11.361

7.  Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress.

Authors:  R S Tibbetts; D Cortez; K M Brumbaugh; R Scully; D Livingston; S J Elledge; R T Abraham
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

8.  Irradiation-induced G2/M checkpoint response requires ERK1/2 activation.

Authors:  Y Yan; C P Black; K H Cowan
Journal:  Oncogene       Date:  2007-02-05       Impact factor: 9.867

9.  Cisplatin-induced response of c-jun N-terminal kinase 1 and extracellular signal--regulated protein kinases 1 and 2 in a series of cisplatin-resistant ovarian carcinoma cell lines.

Authors:  W Cui; E M Yazlovitskaya; M S Mayo; J C Pelling; D L Persons
Journal:  Mol Carcinog       Date:  2000-12       Impact factor: 4.784

Review 10.  Cancer susceptibility and the functions of BRCA1 and BRCA2.

Authors:  Ashok R Venkitaraman
Journal:  Cell       Date:  2002-01-25       Impact factor: 41.582

View more
  12 in total

1.  MEK2 regulates ribonucleotide reductase activity through functional interaction with ribonucleotide reductase small subunit p53R2.

Authors:  Chunmei Piao; Cha-Kyung Youn; Min Jin; Sang Pil Yoon; In-Youb Chang; Jung Hee Lee; Ho Jin You
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

2.  Peroxiredoxin II restrains DNA damage-induced death in cancer cells by positively regulating JNK-dependent DNA repair.

Authors:  Kyung Wha Lee; Doo Jae Lee; Joo Young Lee; Dong Hoon Kang; Jongbum Kwon; Sang Won Kang
Journal:  J Biol Chem       Date:  2010-12-09       Impact factor: 5.157

3.  KSR1 is required for cell cycle reinitiation following DNA damage.

Authors:  Gina L Razidlo; Heidi J Johnson; Scott M Stoeger; Kenneth H Cowan; Tadayoshi Bessho; Robert E Lewis
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

4.  PI 3 kinase related kinases-independent proteolysis of BRCA1 regulates Rad51 recruitment during genotoxic stress in human cells.

Authors:  Ian Hammond-Martel; Helen Pak; Helen Yu; Raphael Rouget; Andrew A Horwitz; Jeffrey D Parvin; Elliot A Drobetsky; El Bachir Affar
Journal:  PLoS One       Date:  2010-11-17       Impact factor: 3.240

5.  ERK1/2 signaling plays an important role in topoisomerase II poison-induced G2/M checkpoint activation.

Authors:  Ryan H Kolb; Patrick M Greer; Phu T Cao; Kenneth H Cowan; Ying Yan
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

6.  Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin.

Authors:  Arti Shukla; Jedd M Hillegass; Maximilian B MacPherson; Stacie L Beuschel; Pamela M Vacek; Harvey I Pass; Michele Carbone; Joseph R Testa; Brooke T Mossman
Journal:  Mol Cancer       Date:  2010-12-15       Impact factor: 27.401

Review 7.  Dual effects of active ERK in cancer: A potential target for enhancing radiosensitivity.

Authors:  Yinliang Lu; Baocai Liu; Ying Liu; Xinyue Yu; Guanghui Cheng
Journal:  Oncol Lett       Date:  2020-05-28       Impact factor: 2.967

8.  Radiosensitization by enzalutamide for human prostate cancer is mediated through the DNA damage repair pathway.

Authors:  Konjeti R Sekhar; Jian Wang; Michael L Freeman; Austin N Kirschner
Journal:  PLoS One       Date:  2019-04-01       Impact factor: 3.240

Review 9.  Radiation-induced signaling pathways that promote cancer cell survival (review).

Authors:  Ashley L Hein; Michel M Ouellette; Ying Yan
Journal:  Int J Oncol       Date:  2014-08-20       Impact factor: 5.650

Review 10.  Regulation of extracellular signal-regulated kinase 1/2 influences hippocampal neuronal survival in a rat model of diabetic cerebral ischemia.

Authors:  Yaning Zhao; Jianmin Li; Qiqun Tang; Pan Zhang; Liwei Jing; Changxiang Chen; Shuxing Li
Journal:  Neural Regen Res       Date:  2014-04-01       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.